Literature DB >> 11408618

Mechanism of mitotic block and inhibition of cell proliferation by the semisynthetic Vinca alkaloids vinorelbine and its newer derivative vinflunine.

V K Ngan1, K Bellman, B T Hill, L Wilson, M A Jordan.   

Abstract

The two second-generation Vinca alkaloids, vinorelbine and vinflunine, affect microtubule dynamics very differently from vinblastine, a first generation Vinca alkaloid. For example, vinblastine strongly suppresses the rate and extent of microtubule shortening in vitro, whereas vinorelbine and vinflunine suppress the rate and extent of microtubule growing events. We asked whether these differences result in differences in mitotic spindle organization that might be responsible for the superior antitumor activities of the two second-generation Vinca alkaloids. IC(50) values for inhibition of HeLa cell proliferation for vinflunine, vinorelbine, and vinblastine were 18, 1.25, and 0.45 nM, respectively, similar to the concentrations that induced mitotic block at the metaphase/anaphase transition (38, 3.8, and 1.1 nM, respectively), indicating that mitotic block is a major contributor to antiproliferative action for all three drugs. Mitotically blocked cells exhibited aberrant spindles, consistent with induction of block by suppression of microtubule dynamics. Despite differences in their actions on individual dynamic instability parameters, morphologically detectable differences in spindle effects among the three drugs were minimal, indicating that overall suppression of dynamics may be more important in blocking mitosis than specific effects on growth or shortening. We also found that the peak intracellular drug concentration at the mitotic IC(50) value was highest for vinflunine (4.2 +/- 0.2 microM), intermediate for vinorelbine (1.3 +/- 0.1 microM), and more than 10-fold lower for vinblastine (130 +/- 7 nM), suggesting that intracellular binding reservoir(s) may be partially responsible for vinflunine's high efficacy and minimal side effects.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11408618     DOI: 10.1124/mol.60.1.225

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  37 in total

1.  Modulation of the anti-cancer efficacy of microtubule-targeting agents by cellular growth conditions.

Authors:  Jay F Dorsey; Melissa L Dowling; Mijin Kim; Ranh Voong; Lawrence J Solin; Gary D Kao
Journal:  Cancer Biol Ther       Date:  2010-05-15       Impact factor: 4.742

2.  Cytotoxic effects of two organotin compounds and their mode of inflicting cell death on four mammalian cancer cells.

Authors:  Armando Varela-Ramirez; Margaret Costanzo; Yazmin P Carrasco; Keith H Pannell; Renato J Aguilera
Journal:  Cell Biol Toxicol       Date:  2010-10-31       Impact factor: 6.691

3.  Antiproliferative cardenolides from Pentopetia androsaemifolia Decne. from the Madagascar rain forest.

Authors:  Eba Adou; James S Miller; Fidisoa Ratovoson; Chris Birkinshaw; Rabodo Andriantsiferana; Vincent E Rasamison; David G I Kingston
Journal:  Indian J Exp Biol       Date:  2010-03       Impact factor: 0.818

4.  OCT4 controls mitotic stability and inactivates the RB tumor suppressor pathway to enhance ovarian cancer aggressiveness.

Authors:  E Comisso; M Scarola; M Rosso; S Piazza; S Marzinotto; Y Ciani; M Orsaria; L Mariuzzi; C Schneider; S Schoeftner; R Benetti
Journal:  Oncogene       Date:  2017-03-20       Impact factor: 9.867

Review 5.  Vinorelbine: a review of its use in elderly patients with advanced non-small cell lung cancer.

Authors:  Monique P Curran; Greg L Plosker
Journal:  Drugs Aging       Date:  2002       Impact factor: 3.923

6.  Engineering overexpression of ORCA3 and strictosidine glucosidase in Catharanthus roseus hairy roots increases alkaloid production.

Authors:  Jiayi Sun; Christie A M Peebles
Journal:  Protoplasma       Date:  2015-09-08       Impact factor: 3.356

7.  Suppression of microtubule dynamic instability and turnover in MCF7 breast cancer cells by sulforaphane.

Authors:  Olga Azarenko; Tatiana Okouneva; Keith W Singletary; Mary Ann Jordan; Leslie Wilson
Journal:  Carcinogenesis       Date:  2008-10-23       Impact factor: 4.944

Review 8.  Peripheral neuropathy and cancer.

Authors:  Arthur D Forman
Journal:  Curr Oncol Rep       Date:  2004-01       Impact factor: 5.075

9.  Computational analysis of image-based drug profiling predicts synergistic drug combinations: applications in triple-negative breast cancer.

Authors:  Miriam B Brandl; Eddy Pasquier; Fuhai Li; Dominik Beck; Sufang Zhang; Hong Zhao; Maria Kavallaris; Stephen T C Wong
Journal:  Mol Oncol       Date:  2014-06-19       Impact factor: 6.603

10.  Murine leukemia P388 vinorelbine-resistant cell lines are sensitive to vinflunine.

Authors:  Ashish Aggarwal; Anna Kruczynski; Anthony Frankfurter; John J Correia; Sharon Lobert
Journal:  Invest New Drugs       Date:  2007-12-11       Impact factor: 3.850

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.